Posted by Michael Wonder on 12 Jul 2023
Ruzurgi is now available and covered by the vast majority of public health and private insurance plans
11 July 2023 - Médunik Canada is pleased to announce that Ruzurgi (amifampridine) is now covered by the vast majority of provincial and federal public health programs and many private insurance plans through special authorisation.
More than 90% of Canadians suffering from Lambert-Eaton myasthenic syndrome will benefit from this extensive coverage.
